دورية أكاديمية

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
المؤلفون: McClung, M. R., Zanchetta, J. R., Racewicz, A., Roux, C., Benhamou, C.-L., Man, Z., Eusebio, R. A., Beary, J. F., Burgio, D. E., Matzkin, E., Boonen, S., Delmas, P.
المصدر: Osteoporosis International: With other metabolic bone diseases. January 2013 24(1):293-299
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:0937941X
14332965
DOI:10.1007/s00198-012-2056-0